Business Description
![NexImmune Inc NexImmune Inc logo](https://static.gurufocus.com/logos/0C0000C1W3.png?14)
NexImmune Inc
NAICS : 541713
SIC : 2834
ISIN : US65344D2080
Share Class Description:
STU:7370: Ordinary SharesDescription
NexImmune Inc is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body's T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. It creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. The company has two product candidates in human trials: NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 64.54 | |||||
Equity-to-Asset | 0.33 | |||||
Debt-to-Equity | 0.02 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 5.1 | |||||
3-Year EPS without NRI Growth Rate | 6.8 | |||||
3-Year FCF Growth Rate | 4.5 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
14-Day RSI | 49.89 | |||||
12-1 Month Momentum % | -30.53 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.3 | |||||
Quick Ratio | 1.3 | |||||
Cash Ratio | 0.96 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.5 | |||||
Shareholder Yield % | -74.34 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -233.74 | |||||
ROA % | -149.83 | |||||
ROIC % | -564.8 | |||||
ROC (Joel Greenblatt) % | -758.48 | |||||
ROCE % | -220 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.15 | |||||
Price-to-Tangible-Book | 1.15 | |||||
EV-to-EBIT | 0.05 | |||||
EV-to-EBITDA | 0.05 | |||||
EV-to-FCF | 0.05 | |||||
Price-to-Net-Current-Asset-Value | 227.5 | |||||
Earnings Yield (Greenblatt) % | 2009.17 | |||||
FCF Yield % | -636.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NexImmune Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -22.339 | ||
Beta | 2.08 | ||
Volatility % | 24.56 | ||
14-Day RSI | 49.89 | ||
14-Day ATR (€) | 0.000007 | ||
20-Day SMA (€) | 4.55 | ||
12-1 Month Momentum % | -30.53 | ||
52-Week Range (€) | 4.025 - 7 | ||
Shares Outstanding (Mil) | 1.37 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
NexImmune Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
NexImmune Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
NexImmune Inc Frequently Asked Questions
What is NexImmune Inc(STU:7370)'s stock price today?
The current price of STU:7370 is €4.55. The 52 week high of STU:7370 is €7.00 and 52 week low is €4.03.
When is next earnings date of NexImmune Inc(STU:7370)?
The next earnings date of NexImmune Inc(STU:7370) is 2024-08-15 Est..
Does NexImmune Inc(STU:7370) pay dividends? If so, how much?
NexImmune Inc(STU:7370) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |